FinancialsFrom what I am hearing, the financials for next quarter reporting should be "significantly improved". Then again, it HAS TO BE! The company continues to set itself up for a snowball effect in terms of continually increasing sales. It's unfortunate that there has been a lack of news releases, however, each quarter from now on should show very good growth in sales. In the meantime, more molecules will be added and thus, further adding to cash being brought in. There's no reason why we shouldn't be north of $1/share at some point next year. It will all be incremental steps, but steps in the right direction is what is ultimately important.